Organization · Venture Capital
Neurone
Neurone is a Luxembourg-based investment holding company that focuses on early and growth stage technology companies globally. They provide operational support and capital to help entrepreneurs scale their ventures.
Overview
What Neurone does
What Neurone is
Neurone is a Luxembourg-based investment holding company that focuses on early and growth stage technology companies globally. They provide operational support and capital to help entrepreneurs scale their ventures.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Neurone elsewhere
Open the official website or a supported primary organization account.
Capability profile
Neurone as a funder
Investment thesis
Neurone identifies and supports entrepreneurs building technology companies to address significant challenges and reimagine future possibilities.
Focus narrative
Neurone invests in technology companies at various stages, from seed to growth. Their investment strategy includes venture capital, growth stage investments, and public equity. In addition to providing capital, Neurone offers operational support to help portfolio companies scale and succeed in their respective markets.
Value beyond capital
Neurone adds value to its portfolio companies by providing not only capital but also operational support. This includes strategic guidance and resources to help entrepreneurs navigate challenges and accelerate growth.
Focus and fit
- Stages
- Seed · Growth Equity
- Sectors
- HealthcareBiotech & Life SciencesSaaS & Cloud SoftwareConsumerClimate & SustainabilityDigital HealthRobotics & Autonomous Systems
- Regions
- Global · Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
Neurone has made investments in companies such as Biocentis, a biotechnology firm, and Verne, which received funding during its Series A round. The firm has a diverse portfolio that spans multiple sectors, including healthcare, information technology, and digital health.
Common questions
What to know about Neurone
Upseed classifies Neurone under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.